The use and efficacy of mucolytic agents.
D000111:Acetylcysteine / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000402:Airway Obstruction / Q000188:drug therapy*; D001249:Asthma / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D002918:Chymotrypsin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003851:Deoxyribonucleases / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012964:Sodium; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use
D001639:Bicarbonates; D005100:Expectorants; D013501:Surface-Active Agents; D012964:Sodium; D013299:Streptodornase and Streptokinase; D003851:Deoxyribonucleases; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D000111:Acetylcysteine